Yes, my opinion on the down grade is the absence of US - and it doesn't look like happening in the next 18 months. Also the apparent added risk to international expansion that wasn't foreseen previously. I.e regulatory problems. It's likely that if we run into this problem in the US, we'll run into others also.
- Forums
- ASX - By Stock
- IMS
- Festive Buying Season
Festive Buying Season, page-25
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online